This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Tak Cheung
Principal at New Enterprise Associates (NEA)

Profile

Tak joined NEA in 2018 as a Principal on the healthcare team. He focuses on medical device investments. He currently serves as a board member of Foundry Therapeutics 1, and Magenta Medical and as a board observer of Ivantis, Lungpacer Medical, Moximed, Relievant Medsystems, and Spyglass Ophthalmics. Prior to NEA, Tak was a Venture Partner at Merieux Development Venture Fund where he led all phases of investment for healthcare startups, including sourcing, diligence and investment approvals. Tak also co-founded Lexington Medical, a commercial-stage medical device startup in the gastrointestinal surgery space. Prior to Merieux and Lexington, Tak was VP of Business Development for the Global Surgical Division at Bausch & Lomb, and was responsible for all business development efforts in the ophthalmic surgical division. Tak has held various corporate and business development leadership roles at Edwards Lifesciences in the Heart Valve Therapy Division and Advanced Medical Optics (acquired by Johnson & Johnson). Tak received a BS with Honors in Engineering and Applied Science from the California Institute of Technology, an MD from the University of California, Irvine, and an MBA from Harvard Business School.

Agenda Sessions

  • Medtech’s role in a transformed future

    On Demand

Speakers at this event